BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Resilient Biotics
Resilient Biotics is utilizing advanced microbiome genomics and data science for prevention and precision treatment of deadly infectious diseases.
